Related Experiment Video
Updated: Aug 11, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Neurocognitive aspects of medication adherence in HIV-positive injecting drug users
Drenna Waldrop-Valverde1, Raymond L Ownby, Frances L Wilkie
1Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida 33101, USA. dwaldrop@med.miami.edu
Abstract:
Cognitive deficits are associated with nonadherence to HIV medications. HIV-positive injecting drug users (IDUs) are at particular risk for nonadherence and cognitive barriers to adherence specific to this population should therefore be identified. The present study assessed the relation of three domains of cognitive functioning, executive functions, memory, and psychomotor speed, to self-reported antiretroviral adherence in a sample of HIV-positive IDUs. Depression, use of alcohol, heroin, cocaine/crack, or marijuana in the last week were also included in the models. Logistic regression analyses showed that only psychomotor slowing was significantly associated with nonadherence. Executive functions, memory, depression, and active alcohol and substance use were unrelated to adherence. No other studies to date have exclusively linked psychomotor slowing to nonadherence in HIV infection. Psychomotor slowing among our study sample was severe and suggests that when evident, such slowing may be a valuable determinant for antiretroviral adherence among IDUs.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dosing: Geriatric Patients
Factors Affecting Drug Response: Overview
Drug Dependence
